The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials

Am J Hematol. 2017 Dec;92(12):E661-E664. doi: 10.1002/ajh.24913. Epub 2017 Oct 19.

Authors

Matteo Molica¹, Martina Canichella¹, Danilo Alunni Fegatelli¹, Gioia Colafigli¹, Fulvio Massaro¹, Roberto Latagliata¹, Robin Foà¹, Massimo Breccia¹

Affiliation

¹ Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, Sapienza University, Rome, Italy.

PMID: 28940255
DOI: 10.1002/ajh.24913

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Clinical Trials as Topic
Disease-Free Survival
Female
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
Male
Predictive Value of Tests
Survival Rate